Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AEs, afatinib, aimed, alter, America, antiviral, area, ArQule, attorney, Biolex, Biomira, BioPharma, Boehringer, Brazil, cabazitaxel, carcinoma, castration, Cetuximab, Chugai, CIS, clear, CMO, coinfected, Commonwealth, cord, cornerstone, counting, crizotinib, CRPC, CureTech, cyclophilin, Daiichi, Danoprevir, DCVax, Debiopharm, Dendreon, dendritic, device, Digna, EMD, ESPP, EVR, expedite, explanation, Filibuvir, Flamel, forfeited, forfeiture, front, Gilead, GlaxoSmithKline, globally, Globeimmune, GS, HanAll, Hanferon, hardware, HCC, hepatocellular, Idera, imatinib, immunomodulatory, Immunotherapy, INCIVEKTM, Ingelheim, iniparib, insignificant, Intercell, interdealer, ipilimumab, Jeffrey, Kingdom, lambda, largest, leaving, Left, Leverage, Locteron, malignant, Maston, Medivir, metastatic, mg, modest, multicenter, neurologic, nitazoxanide, North, Northwest, Novocure, Obama, OpportunityOnce, OS, OTC, OTCQX, panitumumab, pathway, pendency, Pfizer, Pharmasset, polymerase, portable, predictor, prescription, principle, Provenge, quotation, randomly, reimportation, reinvest, resistant, rituximab, Romark, Russia, Sankyo, Serono, served, software, sorafenib, spending, spinal, standalone, Stason, survey, Switzerland, TEVA, TMT, Transgene, trastuzumab, unchanged, unredacted, untreated, UT, virologic, Vlak, voluntary, wearable, world, XL, Yervoy
Removed:
adaptation, albumin, announced, applying, ascending, assay, attending, bioreactor, budgetary, bulletin, characterize, chronic, CMV, cohort, collaborative, collected, confirm, confirmation, deadly, deficiency, documented, dosed, dosimetry, downstream, DTRA, eighty, electronic, Emerging, escalating, exhibiting, Genome, grown, immunodeficiency, influenza, infrequent, Initiative, Institute, letter, limiting, literature, load, master, media, mild, mouth, notifying, offered, optimized, parallel, peak, percent, pharmacologic, poor, positioned, productivity, proposal, purification, regain, repeat, requirement, Schering, serum, sharing, showing, simplified, strain, surgery, Task, TMTI, toxicology, tracked, transient, utilizing, Vasopermeation, weight, word, worth
Filing tables
Filing exhibits
Related press release
CDMO similar filings
Filing view
External links